HIV testing and unreported HIV positivity among injecting drug users in London.
To assess the importance of community-recruited drug injectors with no treatment experience and no previous testing history when estimating HIV prevalence among drug injectors.
HIV testing behaviour and prevalence were measured in a serial point prevalence study of drug inlectors recruited in community-based non-treatment and treatment settings.
Pearson's khi2 and Fisher's exact tests were used to measure differences between treatment groups and non-treatment groups in demographic characteristics, including age and length of injecting career, recent drug use, recent syringe sharing, uptake of previous HIV testing, confirmed HIV-antibody status by saliva and self-reported HIV status.
Mots-clés Pascal : Immunodéficit acquis syndrome, Virose, Infection, Voie intraveineuse, Epidémiologie, Séropositivité, Toxicomanie, Hémopathie, Immunopathologie, Prévalence, Diagnostic, Angleterre, Grande Bretagne, Royaume Uni, Europe, Homme
Mots-clés Pascal anglais : AIDS, Viral disease, Infection, Intravenous administration, Epidemiology, Seropositivity, Drug addiction, Hemopathy, Immunopathology, Prevalence, Diagnosis, England, Great britain, United Kingdom, Europe, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0578534
Code Inist : 002B06D01. Création : 199406.